SLC16A1 and metabolic dysfunction-associated steatohepatitis: The results revealed that CD5L, DUSP8, CD24, and SLC16A1 were significantly different between MASH and control samples and demonstrated strong predictive power for MASH occurrence (Supplementary Figure S1).